Skip to main content
. 2022 May 13;19:79. doi: 10.1186/s12985-022-01812-3

Table 2.

Association between WHO score and MIRNA sequences. The results are reported as crude and sex- and age-adjusted incidence rate ratio (IRR) values and corresponding 95% confidence intervals (95% CIs)

WHO score ≥ 5
(N = 27)
WHO score < 5
(N = 29)
IRRa
(95% CI)
Adjusted IRR
(95% CI)
TTV DNA, copies/ml
 Negative (= 10), N (%) 12 (44) 11 (38) Ref. Ref.
 Positive (> 10), N (%) 15 (56) 18 (62) 0.87 (0.51–1.50) 0.84 (0.47–1.51)
miRNA t1a, copies/ug RNA
 Negative (= 10), N (%) 20 (74) 19 (66) Ref. Ref.
 Positive (> 10), N (%) 7 (26) 10 (34) 0.80 (0.42–1.53) 0.77 (0.41–1.44)
miRNA t3b, copies/ug RNA
 Negative (= 10), N (%) 7 (26) 13 (45) Ref. Ref.
 Positive (> 10), N (%) 20 (74) 16 (55) 1.58 (0.82–3.09) 1.46 (0.74–2.88)
miRNA tth8, copies/ug RNAb
 ≤ 3080, N (%) 10 (37) 20 (69) Ref. Ref.
 > 3080, N (%) 17 (63) 9 (31) 1.96 (1.10–3.50) 2.04 (1.14–3.63)

aIncidence rate ratio (IRR) was calculated using Poisson regression models with robust variance

bAs the TTV miRNA tth8 exhibited a low number of negative values, the median values (3080 copies/μg RNA) obtained using all positive data was used for dichotomous variables. Thus, for miRNA tth8, the data reported in the WHO score ≥ 5 and WHO score < 5 were the number of samples with values ≤ 3080 and those > 3080